Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02542176 · ClinicalTrials.gov registry record · NA
Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02542176 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 20 participants.
The verdict
NCT02542176, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of both chronic and acute grape ingestion in a population of men and women at higher risk for both type 2 diabetes and cardiovascular disease (metabolic syndrome).
Interventions
- OTHER Freeze-dried Whole Grape Powder
- OTHER Grape Powder Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02542176
The ClinicalTrials.gov registry entry for NCT02542176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Freeze-dried Whole Grape Powder is the first listed.
NCT02542176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02542176 about?
NCT02542176 is a clinical study titled "Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome". The purpose of this study is to evaluate the effects of both chronic and acute grape ingestion in a population of men and women at higher risk for both type 2 diabetes and cardiovascular disease (metabolic syndrome).
What is the current status of trial NCT02542176?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-10. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02542176?
The interventions under investigation include: Freeze-dried Whole Grape Powder (OTHER), Grape Powder Placebo (OTHER).
Who is sponsoring clinical trial NCT02542176?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.